Literature DB >> 8295184

Interferon-gamma inhibits proliferation, differentiation, and creatine kinase activity of cultured human muscle cells. II. A possible role in myositis.

A E Kalovidouris1, Z Plotkin, D Graesser.   

Abstract

OBJECTIVE: To investigate the effects of human interferon-gamma (IFN-gamma) on cultured human skeletal muscle cells.
METHODS: Muscle cell cultures were treated with various concentrations of recombinant human IFN-gamma, and muscle cell proliferation, creatine kinase synthesis and muscle cell cytotoxicity were analyzed.
RESULTS: Treatment of muscle cell cultures with IFN-gamma resulted in significant inhibition of myoblasts proliferation, growth, and fusion into multinucleated myotubes. IFN-gamma inhibited creatine kinase synthesis if applied before, but not after, the myoblasts begin to differentiate into myotubes. The effect of IFN-gamma was dose dependent and observed at a concentration of IFN-gamma as low as 10 U/ml. Despite these cytostatic effects, IFN-gamma was not cytotoxic to cultured muscle cells even with very high (10,000 U/ml) IFN-gamma doses.
CONCLUSION: IFN-gamma inhibits muscle cell proliferation and differentiation in vitro. These findings suggest that IFN-gamma, a T cell lymphokine, may inhibit muscle regeneration and the repair of injured muscle fibers in myositis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8295184

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  17 in total

1.  Etanercept-induced myositis: do we have to stop it? A surprising outcome.

Authors:  Hassan Tariq; Bibi Ayesha; Karen Weidenheim; Giovanni Franchin
Journal:  BMJ Case Rep       Date:  2016-01-11

2.  IFN-γ promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation.

Authors:  S Armando Villalta; Bo Deng; Chiara Rinaldi; Michelle Wehling-Henricks; James G Tidball
Journal:  J Immunol       Date:  2011-10-17       Impact factor: 5.422

Review 3.  Cytokines in exertion-induced skeletal muscle injury.

Authors:  J G Cannon; B A St Pierre
Journal:  Mol Cell Biochem       Date:  1998-02       Impact factor: 3.396

Review 4.  Shared signaling systems in myeloid cell-mediated muscle regeneration.

Authors:  James G Tidball; Kenneth Dorshkind; Michelle Wehling-Henricks
Journal:  Development       Date:  2014-03       Impact factor: 6.868

5.  Gamma interferon modulates myogenesis through the major histocompatibility complex class II transactivator, CIITA.

Authors:  Priya Londhe; Judith K Davie
Journal:  Mol Cell Biol       Date:  2011-05-16       Impact factor: 4.272

6.  Neutrophils contribute to muscle injury and impair its resolution after lengthening contractions in mice.

Authors:  Francis X Pizza; Jennifer M Peterson; Joel H Baas; Timothy J Koh
Journal:  J Physiol       Date:  2004-11-18       Impact factor: 5.182

7.  Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy.

Authors:  S Armando Villalta; Wendy Rosenthal; Leonel Martinez; Amanjot Kaur; Tim Sparwasser; James G Tidball; Marta Margeta; Melissa J Spencer; Jeffrey A Bluestone
Journal:  Sci Transl Med       Date:  2014-10-15       Impact factor: 17.956

Review 8.  Inflammation induced loss of skeletal muscle.

Authors:  Priya Londhe; Denis C Guttridge
Journal:  Bone       Date:  2015-11       Impact factor: 4.398

Review 9.  Interferon-γ and other inflammatory mediators in cardiomyocyte signaling during Chagas disease cardiomyopathy.

Authors:  Ludmila Rodrigues Pinto Ferreira; Amanda Farage Frade; Monique Andrade Baron; Isabela Cunha Navarro; Jorge Kalil; Christophe Chevillard; Edecio Cunha-Neto
Journal:  World J Cardiol       Date:  2014-08-26

Review 10.  Aging of the immune system and impaired muscle regeneration: A failure of immunomodulation of adult myogenesis.

Authors:  James G Tidball; Ivan Flores; Steven S Welc; Michelle Wehling-Henricks; Eisuke Ochi
Journal:  Exp Gerontol       Date:  2020-12-24       Impact factor: 4.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.